FindTrial
Sign In

Use of granulocyte colony-stimulating factor (Lenograstim) for the treatment of unexplained recurrent miscarriage

Use of granulocyte colony-stimulating factor (Lenograstim) for the treatment of unexplained recurrent miscarriage - Use of granulocyte colony-stimulating factor (Lenograstim) for the treatment of unexplained recurrent miscarriage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007011
Enrollment
20
Registered
2012-02-01
Start date
2012-02-01
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent miscarriage

Interventions

Lenograstim

Sponsors

Kobe University, Graduate School of Medicine, Deportment of Obstetrics and Gynecology
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: history of allergy to G-CSF

Design outcomes

Primary

MeasureTime frame
the rate of live birth—

Secondary

MeasureTime frame
side effects—

Countries

Japan

Contacts

Public ContactYasuhiko Ebina

Kobe University, Graduate School of Medicine Deportment of Obstetrics and Gynecology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026